Actos has been used for years to reduce blood-sugar levels in patients suffering from Type 2 diabetes, a lawyer for the drug’s manufacturer said Tuesday. It was the second and final day of closing arguments in a Las Vegas trial that began three months ago against Japanese company Takeda Pharmaceuticals.